The contribution of naturally occurring IgM antibodies, IgM cross-reactivity and complement dependency in murine humoral responses to pneumococcal capsular polysaccharides.

[1]  G. Arsequell,et al.  Immunobiology of Carbohydrates , 2010 .

[2]  R. George,et al.  Serotype-Specific Immune Unresponsiveness to Pneumococcal Conjugate Vaccine following Invasive Pneumococcal Disease , 2008, Infection and Immunity.

[3]  D. Goldblatt,et al.  Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease , 2007, Clinical and experimental immunology.

[4]  L. Hammitt,et al.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. , 2007, JAMA.

[5]  C. Snapper,et al.  In Vivo Humoral Immune Responses to Isolated Pneumococcal Polysaccharides Are Dependent on the Presence of Associated TLR Ligands1 , 2005, The Journal of Immunology.

[6]  K. Haas,et al.  B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. , 2005, Immunity.

[7]  T. Honjo,et al.  B1b lymphocytes confer T cell-independent long-lasting immunity. , 2004, Immunity.

[8]  D. Karp,et al.  Cutting Edge: C3d Functions as a Molecular Adjuvant in the Absence of CD21/35 Expression 1 , 2004, The Journal of Immunology.

[9]  H. Ohdan,et al.  Peritoneal Cavity B Cells Are Precursors of Splenic IgM Natural Antibody-Producing Cells 1 , 2003, The Journal of Immunology.

[10]  A. Weintraub.  Immunology of bacterial polysaccharide antigens. , 2003, Carbohydrate research.

[11]  B. Devlin,et al.  Role of different B-cell subsets in the specific and polyclonal immune response to T-independent antigens type 2. , 2003, Immunology letters.

[12]  D. Greenberg,et al.  Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants. , 2003, Vaccine.

[13]  N. Greenspan,et al.  Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein. , 2003, The Journal of infectious diseases.

[14]  D. Kasper,et al.  Impaired Antibody Response to Group B Streptococcal Type III Capsular Polysaccharide in C3- and Complement Receptor 2-Deficient Mice1 , 2003, The Journal of Immunology.

[15]  M. Ehrenstein,et al.  Cutting Edge: Selection of B Lymphocyte Subsets Is Regulated by Natural IgM1 , 2002, The Journal of Immunology.

[16]  D. Karp,et al.  Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. , 2002, Immunity.

[17]  L. Kobzik,et al.  Functional Activity of Natural Antibody is Altered in Cr2-Deficient Mice1 , 2002, The Journal of Immunology.

[18]  Richard J. Stillion,et al.  Recognition of Bacterial Capsular Polysaccharides and Lipopolysaccharides by the Macrophage Mannose Receptor* , 2002, The Journal of Biological Chemistry.

[19]  J. Kearney,et al.  Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. , 2002, Immunity.

[20]  J. Guthridge,et al.  Mice Deficient in Complement Receptors 1 and 2 Lack a Tissue Injury-Inducing Subset of the Natural Antibody Repertoire1 , 2002, The Journal of Immunology.

[21]  H. Käyhty,et al.  Current State of Pneumococcal Vaccines , 2002, Scandinavian journal of immunology.

[22]  H. Wardemann,et al.  B-1a B Cells that Link the Innate and Adaptive Immune Responses Are Lacking in the Absence of the Spleen , 2002, The Journal of experimental medicine.

[23]  P. Lambert,et al.  Adjuvant effects of CpG oligodeoxynucleotides on responses against T‐independent type 2 antigens , 2001, Immunology.

[24]  M. Boes,et al.  Role of natural and immune IgM antibodies in immune responses. , 2000, Molecular immunology.

[25]  H. Ohdan,et al.  Mac-1-Negative B-1b Phenotype of Natural Antibody-Producing Cells, Including Those Responding to Galα1,3Gal Epitopes in α1,3-Galactosyltransferase-Deficient Mice1 , 2000, The Journal of Immunology.

[26]  R. Hardy,et al.  Development and function of B-1 cells. , 2000, Current opinion in immunology.

[27]  S. Black,et al.  Efficacy of pneumococcal conjugate vaccines in large scale field trials , 2000, The Pediatric infectious disease journal.

[28]  Kuijper,et al.  Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement‐deficient patients , 2000, Clinical and experimental immunology.

[29]  I. Maclennan,et al.  Dendritic cells associated with plasmablast survival , 1999, European journal of immunology.

[30]  Jianzhu Chen,et al.  A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection , 1998, The Journal of experimental medicine.

[31]  M. Daha,et al.  Protection against meningococcal serogroup ACYW disease in complement‐deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine , 1998, Clinical and experimental immunology.

[32]  M. Neuberger,et al.  Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Whitmore,et al.  Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. , 1996, International immunology.

[34]  J. Ahearn,et al.  Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. , 1996, Immunity.

[35]  P. Butko,et al.  Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Pangburn,et al.  Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation. , 1993, The Biochemical journal.

[37]  E. Kabat,et al.  Variable region cDNA sequences of three mouse monoclonal anti-idiotypic antibodies specific for anti-alpha(1----6)dextrans with groove- or cavity-type combining sites. , 1992, Molecular immunology.

[38]  L. Arnold,et al.  Autoantibodies to Phosphatidylcholine , 1992, Annals of the New York Academy of Sciences.

[39]  M. Daha,et al.  An association between homozygous C3 deficiency and low levels of anti‐pneumococcal capsular polysaccharide antibodies , 1992, Clinical and experimental immunology.

[40]  M. Forster,et al.  N.m.r. and conformational analysis of the capsular polysaccharide from Streptococcus pneumoniae type 4. , 1991, Carbohydrate research.

[41]  B. Heyman,et al.  Inhibition of immunological memory and T‐independent humoral responses by monoclonal antibodies specific for murine complement receptors , 1991, European journal of immunology.

[42]  P. Densen,et al.  Infectious diseases associated with complement deficiencies , 1991, Clinical Microbiology Reviews.

[43]  F. Finkelman,et al.  Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. , 1991, Journal of immunology.

[44]  S. Szu,et al.  Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. , 1990, Microbial pathogenesis.

[45]  S. Poppema,et al.  Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. , 1989, Journal of immunology.

[46]  M. Pangburn.  Analysis of recognition in the alternative pathway of complement. Effect of polysaccharide size. , 1989, Journal of immunology.

[47]  L. Arnold,et al.  Normal mouse peritoneum contains a large population of Ly-1+ (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes , 1988, The Journal of experimental medicine.

[48]  G. Schiffman,et al.  Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens , 1987, Infection and immunity.

[49]  M. Pichichero,et al.  Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant. , 1986, Journal of immunology.

[50]  M. Pangburn,et al.  Species specificity of recognition by the alternative pathway of complement. , 1985, Journal of immunology.

[51]  D. Kasper,et al.  The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice. , 1982, Journal of immunology.

[52]  D. Briles,et al.  Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae , 1981, Nature.

[53]  J. Winkelstein,et al.  The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. , 1976, Journal of immunology.

[54]  R. Lieberman,et al.  GENETICS OF A NEW IgVH (T15 IDIOTYPE) MARKER IN THE MOUSE REGULATING NATURAL ANTIBODY TO PHOSPHORYLCHOLINE , 1974, The Journal of experimental medicine.

[55]  D. Kasper,et al.  Immunologic response of man to group B meningococcal polysaccharide vaccines. , 1972, The Journal of infectious diseases.

[56]  M. Heidelberger,et al.  Degradation of a pneumococcal type-specific polysaccharide with exposure of group-specificity. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[57]  M. Artenstein,et al.  HUMAN IMMUNITY TO THE MENINGOCOCCUS I. THE ROLE OF HUMORAL ANTIBODIES , 1969 .

[58]  R. Gross,et al.  Hazard of overwhelming infection after splenectomy in childhood. , 1967, The New England journal of medicine.

[59]  S Gordon,et al.  Macrophage receptors and immune recognition. , 2005, Annual review of immunology.

[60]  M. Zidan,et al.  Age-dependent development of the splenic marginal zone in human infants is associated with different causes of death. , 2004, Human pathology.

[61]  I. Maclennan,et al.  Antibody responses to Polysaccharides , 2003 .

[62]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[63]  M. Carroll,et al.  The role of complement and complement receptors in induction and regulation of immunity. , 1998, Annual review of immunology.

[64]  P. Casali,et al.  Structure and function of natural antibodies. , 1996, Current topics in microbiology and immunology.

[65]  M. Walport,et al.  Hereditary deficiency of C3 in animals and humans. , 1993, International reviews of immunology.